A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants
Clinical trial NCT05906836 · COMPLETED
Trial details
- NCT number
- NCT05906836
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-27
- Primary completion
- 2023-10-31
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.